Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AVAVA MIRIA General Use

NCT06868615 is registered in ClinicalTrials.gov with AVAVA, Inc. as lead sponsor.

NCT NCT06868615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06868615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AVAVA MIRIA General Use
Lead sponsor
AVAVA, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
September 11, 2024
Completion date
December 30, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne, acne scars - mixed atrophic and hypertrophic, pigment; lesion, scars, skin texture disorder, wrinkle